Literature DB >> 22569889

Misclassification and discordance of measured blood pressure from patient's true blood pressure in current clinical practice: a clinical trial simulation case study.

Yuyan Jin1, Robert Bies, Marc R Gastonguay, Norman Stockbridge, Jogarao Gobburu, Rajanikanth Madabushi.   

Abstract

Treatment decisions for hypertension using sphygmomanometer based measurements and the current clinical practice paradigm do not account for the timing of blood pressure (BP) measurement. This study aimed to evaluate the clinical implications of discordance between measured and true BP, to quantify BP misclassification rate at a typical clinical visit in current clinical practice, and to propose a BP calibration system to decrease the impact of timing of BP measurement. A clinical trial simulation case study was performed using an in silico Monte Carlo Simulation approach. The time-courses of BPs with and without an antihypertensive treatment effect were simulated from a baseline BP model combined with an antihypertensive PK/PD model. Virtual subject characteristics were sampled from the FDA internal database. The baseline BP model was qualified using observed 24 h ambulatory BP monitoring (ABPM) data from 225 subjects by a visual predictive check as well as a global sensitivity analysis. First of all, our results showed that the measured cuff BP in current typical clinical practice deviated from the true values. (1) Cuff BP deviated from the true values by more than 5 mmHg in 57 % (95 % CI: 54-61 %) of patients and more than 10 mmHg in 26 % (95 % CI: 22-32 %) of patients respectively. (2) These discordances were reduced to 28 % (deviation ≥ 5 mmHg, 95 % CI: 18-40 %) and 9 % (deviation ≥ 10 mmHg, 95 % CI: 4-18%) of patients assuming perfect sphygmomanometer measurement and thus represent the contribution of ignoring the daily circadian rhythm of BP. Secondly, our results showed 23-32 % of patients were misclassified to an incorrect BP category for a casual clinical visit based on JNC 7 guideline. In addition, the accuracy of the measured cuff BP varied by time of clinic visit. Specifically, 11:00 AM to 3:00 PM was identified to be the better time frame, while times before 9:00 AM were the worst time frame. Therefore, clinic visit time may need to be adjusted accordingly. Finally, we proposed an easy BP calibration method for clinic use to adjust for time of day differences due to circadian variability in case that the desirable clinic visit time cannot be tailored for practical reasons.

Entities:  

Mesh:

Year:  2012        PMID: 22569889     DOI: 10.1007/s10928-012-9250-8

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  28 in total

1.  A new model for diurnal blood pressure profiling. Square wave fit compared with conventional methods.

Authors:  R N Idema; E S Gelsema; G J Wenting; J L Grashuis; A H van den Meiracker; R M Brouwer; A J Man in 't Veld
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

2.  Analysis and interpretation of 24-h blood pressure profiles: appropriate mathematical models may yield deeper understanding.

Authors:  Gianfranco Parati; Bernard Vrijens; Gábor Vincze
Journal:  Am J Hypertens       Date:  2008-02       Impact factor: 2.689

3.  Accuracy of prehospital sphygmomanometers.

Authors:  J S Jones; W Ramsey; T Hetrick
Journal:  J Emerg Med       Date:  1987       Impact factor: 1.484

4.  Blood pressure measurement error: its effect on cross-sectional and trend analyses.

Authors:  S Bennett
Journal:  J Clin Epidemiol       Date:  1994-03       Impact factor: 6.437

5.  Determinants of masked hypertension in the general population: the Finn-Home study.

Authors:  Marjo-Riitta A Hänninen; Teemu J Niiranen; Pauli J Puukka; Aino K Mattila; Antti M Jula
Journal:  J Hypertens       Date:  2011-10       Impact factor: 4.844

6.  A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings.

Authors:  Geoffrey A Head; Kanella Chatzivlastou; Elena V Lukoshkova; Garry L Jennings; Chris M Reid
Journal:  Am J Hypertens       Date:  2010-06-17       Impact factor: 2.689

7.  Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

8.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

9.  Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension.

Authors:  Cathy B Spranger; Andrea J Ries; Carrie A Berge; Nina B Radford; Ronald G Victor
Journal:  Am J Med       Date:  2004-07-01       Impact factor: 4.965

10.  Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John W Graves; Martha N Hill; Daniel H Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-02       Impact factor: 3.738

View more
  9 in total

Review 1.  Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical Outcomes.

Authors:  Alison F Smith; Bethany Shinkins; Peter S Hall; Claire T Hulme; Mike P Messenger
Journal:  Clin Chem       Date:  2019-08-23       Impact factor: 8.327

2.  Predicted impact of various clinical practice strategies on cardiovascular risk for the treatment of hypertension: a clinical trial simulation study.

Authors:  Yuyan Jin; Robert Bies; Marc R Gastonguay; Yaning Wang; Norman Stockbridge; Jogarao Gobburu; Rajanikanth Madabushi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-18       Impact factor: 2.745

Review 3.  Prevalence of white coat and masked hypertension in Africa: A systematic review and meta-analysis.

Authors:  Jean Jacques Noubiap; Jobert Richie Nansseu; Jan René Nkeck; Ulrich Flore Nyaga; Jean Joel Bigna
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-09       Impact factor: 3.738

4.  Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies.

Authors:  S Karovic; Y Wen; T G Karrison; G L Bakris; M R Levine; L K House; K Wu; V Thomeas; M A Rudek; J J Wright; E E W Cohen; G F Fleming; M J Ratain; M L Maitland
Journal:  Clin Pharmacol Ther       Date:  2014-03-17       Impact factor: 6.875

5.  Predicting out-of-office blood pressure level using repeated measurements in the clinic: an observational cohort study.

Authors:  James P Sheppard; Roger Holder; Linda Nichols; Emma Bray; F D Richard Hobbs; Jonathan Mant; Paul Little; Bryan Williams; Sheila Greenfield; Richard J McManus
Journal:  J Hypertens       Date:  2014-11       Impact factor: 4.844

6.  Prospective Register Of patients undergoing repeated OFfice and Ambulatory Blood Pressure Monitoring (PROOF-ABPM): protocol for an observational cohort study.

Authors:  James P Sheppard; Una Martin; Paramjit Gill; Richard Stevens; Richard J McManus
Journal:  BMJ Open       Date:  2016-10-31       Impact factor: 2.692

7.  Scaling up the use of home blood pressure monitoring in the management of hypertension in low-income countries: A step towards curbing the burden of hypertension.

Authors:  Valirie Ndip Agbor; Mazou N Temgoua; Jean Jacques N Noubiap
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-03-31       Impact factor: 3.738

8.  Predicting Out-of-Office Blood Pressure in the Clinic (PROOF-BP): Derivation and Validation of a Tool to Improve the Accuracy of Blood Pressure Measurement in Clinical Practice.

Authors:  James P Sheppard; Richard Stevens; Paramjit Gill; Una Martin; Marshall Godwin; Janet Hanley; Carl Heneghan; F D Richard Hobbs; Jonathan Mant; Brian McKinstry; Martin Myers; David Nunan; Alison Ward; Bryan Williams; Richard J McManus
Journal:  Hypertension       Date:  2016-03-21       Impact factor: 10.190

9.  Prospective external validation of the Predicting Out-of-OFfice Blood Pressure (PROOF-BP) strategy for triaging ambulatory monitoring in the diagnosis and management of hypertension: observational cohort study.

Authors:  James P Sheppard; Una Martin; Paramjit Gill; Richard Stevens; Fd Richard Hobbs; Jonathan Mant; Marshall Godwin; Janet Hanley; Brian McKinstry; Martin Myers; David Nunan; Richard J McManus
Journal:  BMJ       Date:  2018-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.